Status:
UNKNOWN
Cohort Study for Patients Using Fuzeon (Enfuvirtide)
Lead Sponsor:
Institute for Interdisciplinary Infectiology
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
HIV Infections
Antiretroviral Treatment
Eligibility:
All Genders
Brief Summary
The Radata-Fuzeon cohort is an observational cohort study to gain a better understanding of Fuzeon (Enfuvirtide) in daily clinical practice. Patients planned to take this drug in a new antiretroviral ...
Eligibility Criteria
Inclusion
- Diagnosis of HIV-Infection
- Planned to switch to a Fuzeon-containing antiretroviral therapy
Exclusion
- Inability to understand or sign inform consent
Key Trial Info
Start Date :
May 1 2003
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00216359
Start Date
May 1 2003
End Date
December 1 2006
Last Update
October 25 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ifi-Institute for Interdisciplinary Infectiology
Hamburg, Germany, D-20099